Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/1999
03/30/1999US5889000 Naphthofluorene compounds, intermediates, compositions and methods
03/30/1999US5888994 Anticancer agnets; antitumor agents; glandular disorders
03/30/1999US5888991 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
03/30/1999US5888816 Cell cultures of and cell culturing method for nontransformed pancreatic, thyroid, and parathyroid cells
03/30/1999US5888705 Pancreatic cells to treat type 1 diabetes mellitus. the invention relates to the use of a human cytokine, hepatocyte growth factor/scatter factor (?hgf/sf?).
03/30/1999US5888507 Treatment for insulin dependent diabetes
03/30/1999CA2249049A1 Chromene derivatives and salts thereof, and pharmaceuticals containing the same
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014239A1 Composition for treating diabetes mellitus and obesity
03/25/1999WO1999014215A1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
03/25/1999WO1999014213A1 Substituted chroman derivatives
03/25/1999WO1999014212A1 Substituted chroman derivatives
03/25/1999WO1999014207A1 Substituted indan derivatives
03/25/1999WO1999013910A1 Neovascularization inhibitor
03/25/1999WO1998051330A9 Method and compositions for treating hyperlipidemia and other conditions
03/25/1999DE19741400A1 New benzyl-biphenyl derivatives
03/25/1999DE19741399A1 New tetrahydroquinoline derivatives useful in treatment of elevated lipid levels and arteriosclerosis
03/25/1999DE19741051A1 New tetrahydroquinoline derivatives useful in treatment of raised lipid levels and arteriosclerosis
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2304037A1 Substituted chroman derivatives
03/25/1999CA2303926A1 Substituted chroman derivatives
03/25/1999CA2303839A1 Substituted indan derivatives
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/24/1999EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999EP0903339A2 Biphenylsulfonylcyanamides, process for their preparation and their use as medicaments
03/24/1999EP0903143A2 Use of daidzein for the manufacture of a medicament for incraesing HDL cholesterol levels
03/24/1999EP0902779A2 Phosphate mimics
03/24/1999EP0902669A1 Method suitable for influencing the ingestion of food by humans via the mouth cavity
03/24/1999EP0902624A1 Composition and its use as a food supplement or for lowering lipids in serum
03/24/1999EP0788512B1 Proinsulin peptide compounds for detecting and treating type i diabetes
03/24/1999CN1211991A Compounds with growth hormone releasing properties
03/24/1999CN1211921A Benzothiophenes, formulations containing same and process of preparing same
03/24/1999CN1211441A Preparation method for medicine of reducing blood sugar using natural bitter gourd extract
03/24/1999CN1211423A Fe-Ca nutrient combination and its preparation method
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5886014 Benzimidazole derivatives, their preparation and their therapeutic use
03/23/1999US5886008 5-arylindole derivatives
03/23/1999US5885968 For hypolipidemic medicines
03/23/1999US5885964 Administering to the patient suffering from osteoporosis an effective amount of an agent comprising kininogen or kininogen peptide to prevent bone resorption
03/23/1999US5885595 Treating skin disorder with acne, follicular and lesional papules, actinic keratoses, oily skin and rosacea
03/23/1999US5885583 Method for inhibiting hyperlipemia with emmeisou or an extract thereof
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA2072624C Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
03/23/1999CA1340463C Alkanophenones
03/22/1999CA2247749A1 Biphenylsulfonylcyanamides, process for their preparation, and their use as medicament
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012970A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
03/18/1999WO1999012969A1 Treatment of obesity
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012961A1 Estrogen receptor
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012926A1 Tetrahydro gamma-carbolines
03/18/1999WO1999012916A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012875A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012554A1 Chemical supplementation of bone
03/18/1999WO1999012538A1 Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1999012522A1 High and low load formulations of igf-i in multivesicular liposomes
03/18/1999WO1998057987A3 Irs-p53h, human insulin receptor tyrosine kinase substrate
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303444A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303347A1 Chemical supplementation of bone
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2301969A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
03/18/1999CA2301807A1 Tetrahydro gamma-carbolines
03/18/1999CA2296358A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/17/1999EP0902036A1 Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
03/17/1999EP0902002A1 New derivatives of phthalaldehyde, process for their preparation and their use
03/17/1999EP0901755A2 Cholesterol oxide adsorbing agent and processes for its production and use
03/17/1999EP0901503A1 Synthetic glucagon binding proteins
03/17/1999EP0901484A1 Substituted 1, 3-benzodioxoles
03/17/1999EP0779076A4 Peptide, a method of obtaining it and a pharmaceutical compound based on it
03/17/1999EP0737070A4 Vitamin d 3? analogues and pathway to mediate disorders
03/17/1999EP0708774B1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
03/17/1999EP0678087B1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999CN1211238A Benzimidazole derivatives
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
03/17/1999CN1042539C 11,21-bisphenyl-19-norpregnane derivatives
03/17/1999CN1042532C Substituted phenyltrifluoethoxypropionic acid and its use
03/16/1999US5883294 Selective thyroid hormone analogs
03/16/1999US5883137 Compositions and methods for the control of smoking
03/16/1999US5883133 Cardiovascular disorders
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5883109 Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
03/16/1999US5883099 Treatment of athersclerosis, pancreatitis obesity or hyperglycemia
1 ... 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 ... 1298